GlassScriptPhysician profile
Leslie M Partem
NPI 1689823403
$731.55
in general payments reported to CMS, 2019-2025
18 companies · $88.67 in 2025
The $88.67 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $233 · 2020: $98.25 · 2022: $16.56 · 2023: $39.88 · 2024: $256 · 2025: $88.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $384.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $384.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $125.56 | 2019-2025 | Airsupra, Farxiga |
| Phathom Pharmaceuticals, INC. | $124.99 | 2024 | Voquezna |
| Pfizer INC. | $100.18 | 2019-2025 | |
| Glaxosmithkline, LLC. | $58.33 | 2023-2025 | Shingrix, Arexvy |
| Amgen INC. | $53.58 | 2019-2024 | Repatha, Otezla |
| Novo Nordisk INC | $52.74 | 2019 | |
| Amarin Pharma, INC. | $28.01 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $24.51 | 2019 | |
| Astellas Pharma US INC | $23.67 | 2024 | Veozah |
| Exact Sciences Corporation | $22.27 | 2025 | The Cologuard Plus Collection Kit |
| Merck Sharp & Dohme LLC | $19.36 | 2023 | Verquvo |
| Allergan, INC. | $17.19 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.41 | 2019 | |
| Abbvie INC. | $14.92 | 2019 | |
| Lifescan, INC. | $14.59 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $12.41 | 2020 | |
| Janssen Pharmaceuticals, INC | $11.54 | 2019 | |
| Lilly USA, LLC | $11.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leslie Partem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.